![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
A Schrammel, S Behrends, K Schmidt, D Koesling and B Mayer
Institut fur Pharmakologie und Toxikologie, Karl-Franzens-Universitat Graz, Austria.
Nitric oxide (NO) binds with high affinity to the heme of soluble guanylyl cyclase (sGC), resulting in accumulation of the second messenger cGMP in many biological systems. 1H-[1,2,4]Oxadiazolo[4,3- a]quinoxalin-1-one (ODQ) was recently described as potent and selective inhibitor of sGC, providing an invaluable tool with which to settle the function of the cGMP pathway in NO-mediated signal transduction [Mol. Pharmacol. 48:184-188 (1995)]. The present study investigated the mechanism of ODQ-induced inhibition of purified bovine lung sGC. The drug induced a rightward shift of the concentration-response curves recorded with two different NO donors and a reduction of maximal sGC activity, pointing to a mixed type of inhibition. The time course of NO- stimulated sGC activity determined in the presence of 0.3 microM ODQ showed that the inhibitory effect was time-dependent (half-time approximately 3 min) and virtually complete after about 10 min. The cyclase did not recover from ODQ-induced inhibition upon extensive dilution, pointing to an apparently irreversible inactivation of the enzyme by the quinoxalin. Light absorbance spectroscopy showed that ODQ (0.3 mM) induced a shift of the Soret band of the heme from 431 nm to 393 nm, indicating that ODQ oxidizes the ferrous form of the enzyme to the ferric species, which is though to exhibit only poor NO sensitivity. Together, our results suggest that inhibition of sGC by ODQ is NO-competitive and results in an apparently irreversible oxidation of the prosthetic heme group.
This article has been cited by other articles:
|
|
 |
|
  M. Beretta, K. Gruber, A. Kollau, M. Russwurm, D. Koesling, W. Goessler, W. M. Keung, K. Schmidt, and B. Mayer Bioactivation of Nitroglycerin by Purified Mitochondrial and Cytosolic Aldehyde Dehydrogenases J. Biol. Chem., June 27, 2008; 283(26): 17873 - 17880. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. M. Nausch, J. Ledoux, A. D. Bonev, M. T. Nelson, and W. R. Dostmann Differential patterning of cGMP in vascular smooth muscle cells revealed by single GFP-linked biosensors PNAS, January 8, 2008; 105(1): 365 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. V. Evgenov, D. S. Kohane, K. D. Bloch, J.-P. Stasch, G. P. Volpato, E. Bellas, N. V. Evgenov, E. S. Buys, M. J. Gnoth, A. R. Graveline, et al. Inhaled Agonists of Soluble Guanylate Cyclase Induce Selective Pulmonary Vasodilation Am. J. Respir. Crit. Care Med., December 1, 2007; 176(11): 1138 - 1145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Vanneste, I. Dhaese, P. Sips, E. Buys, P. Brouckaert, and R. A. Lefebvre Gastric motility in soluble guanylate cyclase {alpha}1 knock-out mice J. Physiol., November 1, 2007; 584(3): 907 - 920. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Teixeira, F. B. M. Priviero, and R. C. Webb Effects of 5-Cyclopropyl-2-[1-(2-fluoro-benzyl)-1H-pyrazolo[3,4-b]pyridine-3-yl]pyrimidin-4-ylamine (BAY 41-2272) on Smooth Muscle Tone, Soluble Guanylyl Cyclase Activity, and NADPH Oxidase Activity/Expression in Corpus Cavernosum from Wild-Type, Neuronal, and Endothelial Nitric-Oxide Synthase Null Mice J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1093 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Munzel, S. Genth-Zotz, and U. Hink Targeting Heme-Oxidized Soluble Guanylate Cyclase: Solution for All Cardiorenal Problems in Heart Failure? Hypertension, May 1, 2007; 49(5): 974 - 976. [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Stasch, P.M. Schmidt, P.I. Nedvetsky, T.Y. A. Nedvetskaya, H.S. Kumar, S. Meurer, M. Deile, A. Taye, A. Knorr, H. Lapp, et al. Endothelial Cell Dysfunction--Can One Outsmart Oxidative Stress by Direct Interaction with the Pathological Oxidized or Heme-Free Soluble Guanyl-Cyclase?: Targeting the Heme-Oxydized Nitric Oxide Receptor for Selective Vasodilatation of Diseased Blood Vessels. J Clin Invest 116: 2552-2561, 2006 J. Am. Soc. Nephrol., March 1, 2007; 18(3): 663 - 669. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Duranski, J. W. Elrod, J. W. Calvert, N. S. Bryan, M. Feelisch, and D. J. Lefer Genetic overexpression of eNOS attenuates hepatic ischemia-reperfusion injury Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2980 - H2986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Mingone, S. A. Gupte, J. L. Chow, M. Ahmad, N. G. Abraham, and M. S. Wolin Protoporphyrin IX generation from {delta}-aminolevulinic acid elicits pulmonary artery relaxation and soluble guanylate cyclase activation. Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L337 - L344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Lakshminrusimha, J. A. Russell, S. F. Gugino, R. M. Ryan, B. Mathew, L. C. Nielsen, and F. C. Morin III Adjacent bronchus attenuates pulmonary arterial contractility Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L473 - L478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Teixeira, F. B. M. Priviero, and R. C. Webb Molecular Mechanisms Underlying Rat Mesenteric Artery Vasorelaxation Induced by the Nitric Oxide-Independent Soluble Guanylyl Cyclase Stimulators BAY 41-2272 [5-Cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 258 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Schindler, H. Strobel, K. Schonafinger, W. Linz, M. Lohn, P. A. Martorana, H. Rutten, P. W. Schindler, A. E. Busch, M. Sohn, et al. Biochemistry and Pharmacology of Novel Anthranilic Acid Derivatives Activating Heme-Oxidized Soluble Guanylyl Cyclase Mol. Pharmacol., April 1, 2006; 69(4): 1260 - 1268. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Marjanovic, Z. Li, A. Stojanovic, and X. Du Stimulatory Roles of Nitric-oxide Synthase 3 and Guanylyl Cyclase in Platelet Activation J. Biol. Chem., November 11, 2005; 280(45): 37430 - 37438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Culmsee, N. Gerling, S. Landshamer, B. Rickerts, H.-J. Duchstein, K. Umezawa, S. Klumpp, and J. Krieglstein Nitric Oxide Donors Induce Neurotrophin-Like Survival Signaling and Protect Neurons against Apoptosis Mol. Pharmacol., October 1, 2005; 68(4): 1006 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Cechova and T. N. Pajewski The Soluble Guanylyl Cyclase Inhibitor ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, Dose-Dependently Reduces the Threshold for Isoflurane Anesthesia in Rats Anesth. Analg., September 1, 2004; 99(3): 752 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Huang, S. H. H. Chan, and K.-S. Hsu 3-Morpholinylsydnonimine Inhibits Glutamatergic Transmission in Rat Rostral Ventrolateral Medulla via Peroxynitrite Formation and Adenosine Release Mol. Pharmacol., September 1, 2004; 66(3): 492 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. H. Mauban and W. G. Wier Essential role of EDHF in the initiation and maintenance of adrenergic vasomotion in rat mesenteric arteries Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H608 - H616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gille, G. H. Lushington, T.-C. Mou, M. B. Doughty, R. A. Johnson, and R. Seifert Differential Inhibition of Adenylyl Cyclase Isoforms and Soluble Guanylyl Cyclase by Purine and Pyrimidine Nucleotides J. Biol. Chem., May 7, 2004; 279(19): 19955 - 19969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Schmidt, M. Schramm, H. Schroder, F. Wunder, and J.-P. Stasch Identification of Residues Crucially Involved in the Binding of the Heme Moiety of Soluble Guanylate Cyclase J. Biol. Chem., January 23, 2004; 279(4): 3025 - 3032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Bergandi, F. Silvagno, I. Russo, C. Riganti, G. Anfossi, E. Aldieri, D. Ghigo, M. Trovati, and A. Bosia Insulin Stimulates Glucose Transport Via Nitric Oxide/Cyclic GMP Pathway in Human Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2215 - 2221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nakao, K. Kimizuka, D. B. Stolz, J. S. Neto, T. Kaizu, A. M. K. Choi, T. Uchiyama, B. S. Zuckerbraun, M. A. Nalesnik, L. E. Otterbein, et al. Carbon Monoxide Inhalation Protects Rat Intestinal Grafts from Ischemia/Reperfusion Injury Am. J. Pathol., October 1, 2003; 163(4): 1587 - 1598. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Mingone, S. A. Gupte, T. Iesaki, and M. S. Wolin Hypoxia enhances a cGMP-independent nitric oxide relaxing mechanism in pulmonary arteries Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L296 - L304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Friebe and D. Koesling Regulation of Nitric Oxide-Sensitive Guanylyl Cyclase Circ. Res., July 25, 2003; 93(2): 96 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Walia, S. E. Samson, T. Schmidt, K. Best, M. Whittington, C. Y. Kwan, and A. K. Grover Peroxynitrite and nitric oxide differ in their effects on pig coronary artery smooth muscle Am J Physiol Cell Physiol, March 1, 2003; 284(3): C649 - C657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Bellamy, C. Griffiths, and J. Garthwaite Differential Sensitivity of Guanylyl Cyclase and Mitochondrial Respiration to Nitric Oxide Measured Using Clamped Concentrations J. Biol. Chem., August 23, 2002; 277(35): 31801 - 31807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Kodani, Y.-T. Xuan, H. Takano, K. Shinmura, X.-L. Tang, and R. Bolli Role of Cyclic Guanosine Monophosphate in Late Preconditioning in Conscious Rabbits Circulation, June 25, 2002; 105(25): 3046 - 3052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Martin, Y.-C. Lee, and F. Murad YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components PNAS, October 25, 2001; (2001) 231486198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Ferreyra and D. A. Golombek Rhythmicity of the cGMP-related signal transduction pathway in the mammalian circadian system Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1348 - R1355. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Elphick and R Melarange Neural control of muscle relaxation in echinoderms J. Exp. Biol., January 3, 2001; 204(5): 875 - 885. [Abstract] [PDF]
|
|
|
|
 |
|
 L. A. Kirkman, L. M. Weiss, and K. Kim Cyclic Nucleotide Signaling in Toxoplasma gondii Bradyzoite Differentiation Infect. Immun., January 1, 2001; 69(1): 148 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Meini, A. Benocci, M. Frosini, G. Sgaragli, G. Pessina, C. Aldinucci, G. T. Youmbi, and M. Palmi Nitric Oxide Modulation of Interleukin-1{beta}-Evoked Intracellular Ca2+ Release in Human Astrocytoma U-373 MG Cells and Brain Striatal Slices J. Neurosci., December 15, 2000; 20(24): 8980 - 8986. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Lee, E. Martin, and F. Murad Human recombinant soluble guanylyl cyclase: Expression, purification, and regulation PNAS, September 19, 2000; (2000) 190333697. [Abstract] [Full Text]
|
|
|
|
|
|
R. P. Brandes, F.-H. Schmitz-Winnenthal, M. Feletou, A. Godecke, P. L. Huang, P. M. Vanhoutte, I. Fleming, and R. Busse An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice PNAS, August 15, 2000; 97(17): 9747 - 9752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Bellamy, J. Wood, D. A. Goodwin, and J. Garthwaite Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses PNAS, March 14, 2000; 97(6): 2928 - 2933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. L. Tseng, M. A. Tabrizi-Fard, and H.-L. Fung Differential Sensitivity among Nitric Oxide Donors toward ODQ-Mediated Inhibition of Vascular Relaxation J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 737 - 742. [Abstract] [Full Text]
|
|
|
|
|
|
R. P. Brandes, D.-y. Kim, F.-H. Schmitz-Winnenthal, M. Amidi, A. Godecke, A. Mulsch, and R. Busse Increased Nitrovasodilator Sensitivity in Endothelial Nitric Oxide Synthase Knockout Mice : Role of Soluble Guanylyl Cyclase Hypertension, January 1, 2000; 35(1): 231 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Baumann, C. Blass, R. Gotz, and S. Dragon Ontogeny of Catecholamine and Adenosine Receptor-Mediated cAMP Signaling of Embryonic Red Blood Cells: Role of cGMP-Inhibited Phosphodiesterase 3 and Hemoglobin Blood, December 15, 1999; 94(12): 4314 - 4320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. Gupte, T. Rupawalla, D. Phillibert Jr., and M. S. Wolin NADPH and heme redox modulate pulmonary artery relaxation and guanylate cyclase activation by NO Am J Physiol Lung Cell Mol Physiol, December 1, 1999; 277(6): L1124 - L1132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iesaki, S. A. Gupte, and M. S. Wolin A Flavoprotein Mechanism Appears to Prevent an Oxygen-Dependent Inhibition of cGMP-Associated Nitric Oxide-Elicited Relaxation of Bovine Coronary Arteries Circ. Res., November 26, 1999; 85(11): 1027 - 1031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Li, N. Zhou, and R. A. Johns Soluble guanylate cyclase gene expression and localization in rat lung after exposure to hypoxia Am J Physiol Lung Cell Mol Physiol, October 1, 1999; 277(4): L841 - L847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Iesaki, S. A. Gupte, P. M. Kaminski, and M. S. Wolin Inhibition of guanylate cyclase stimulation by NO and bovine arterial relaxation to peroxynitrite and H2O2 Am J Physiol Heart Circ Physiol, September 1, 1999; 277(3): H978 - H985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Feelisch, P. Kotsonis, J. Siebe, B. Clement, and H. H. H. W. Schmidt The Soluble Guanylyl Cyclase Inhibitor 1H-[1,2,4]Oxadiazolo[4,3,-a]quinoxalin-1-one Is a Nonselective Heme Protein Inhibitor of Nitric Oxide Synthase and Other Cytochrome P-450 Enzymes Involved in Nitric Oxide Donor Bioactivation Mol. Pharmacol., August 1, 1999; 56(2): 243 - 253. [Abstract] [Full Text]
|
|
|
|
|
|
T. Jilling, I. Y. Haddad, S. H. Cheng, and S. Matalon Nitric oxide inhibits heterologous CFTR expression in polarized epithelial cells Am J Physiol Lung Cell Mol Physiol, July 1, 1999; 277(1): L89 - L96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Noll, H. Holschermann, K. Koprek, D. Gunduz, W. Haberbosch, H. Tillmanns, and H. M. Piper ATP reduces macromolecule permeability of endothelial monolayers despite increasing [Ca2+]i Am J Physiol Heart Circ Physiol, June 1, 1999; 276(6): H1892 - H1901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nighorn, K. A. Byrnes, and D. B. Morton Identification and Characterization of a Novel beta Subunit of Soluble Guanylyl Cyclase That Is Active in the Absence of a Second Subunit and Is Relatively Insensitive to Nitric Oxide J. Biol. Chem., January 22, 1999; 274(4): 2525 - 2531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schrammel, S. Pfeiffer, K. Schmidt, D. Koesling, and B. Mayer Activation of Soluble Guanylyl Cyclase by the Nitrovasodilator 3-Morpholinosydnonimine Involves Formation of S-Nitrosoglutathione Mol. Pharmacol., July 1, 1998; 54(1): 207 - 212. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. G. Jenner and M. F. Brin Levodopa neurotoxicity: Experimental studies versus clinical relevance Neurology, June 1, 1998; 50(6_Suppl_6): S39 - S43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Mayer, S. Pfeiffer, A. Schrammel, D. Koesling, K. Schmidt, and F. Brunner A New Pathway of Nitric Oxide/Cyclic GMP Signaling Involving S-Nitrosoglutathione J. Biol. Chem., February 6, 1998; 273(6): 3264 - 3270. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Meng, C. Ayata, C. Waeber, P. L. Huang, and M. A. Moskowitz Neuronal NOS-cGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H411 - H415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Fouty, P. Komalavilas, M. Muramatsu, A. Cohen, I. F. McMurtry, T. M. Lincoln, and D. M. Rodman Protein kinase G is not essential to NO-cGMP modulation of basal tone in rat pulmonary circulation Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H672 - H678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Vadakekalam, M. E. Rabaglia, and S. A. Metz Interleukin-1beta inhibits phospholipase C and insulin secretion at sites apart from KATP channel Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E942 - E950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Sobey and F. M. Faraci Effects of a Novel Inhibitor of Guanylyl Cyclase on Dilator Responses of Mouse Cerebral Arterioles Stroke, April 1, 1997; 28(4): 837 - 843. [Abstract] [Full Text]
|
|
|
|
|
|
L. J. Olson, E. T. Knych Jr, T. C. Herzig, and J. G. Drewett Selective Guanylyl Cyclase Inhibitor Reverses Nitric Oxide-Induced Vasorelaxation Hypertension, January 1, 1997; 29(1): 254 - 261. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Bellamy and J. Garthwaite Sub-second Kinetics of the Nitric Oxide Receptor, Soluble Guanylyl Cyclase, in Intact Cerebellar Cells J. Biol. Chem., February 2, 2001; 276(6): 4287 - 4292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Lee, E. Martin, and F. Murad Human recombinant soluble guanylyl cyclase: Expression, purification, and regulation PNAS, September 26, 2000; 97(20): 10763 - 10768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Martin, Y.-C. Lee, and F. Murad YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components PNAS, November 6, 2001; 98(23): 12938 - 12942. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
